About Trishula therapeutics, inc.

Reviews 11

4.1

About company

Trishula Therapeutics is dedicated to improving outcomes for people with cancer by developing TTX-030, a first-in-class anti-CD39 antibody.

US 4000 shoreline court

Unknown

Not verified company